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STUDIES OF HYPOXEMIC/REOXYGENATION INJURY: 
I. Linkage between cardiac function and oxidant damage 
Gerald D. Buckberg, MD, Los Angeles, Calif. 
S urgical correction of cardiac defects causing cy- anosis is done with the use of cardiopulmonary 
bypass (CPB) in early infancy with increasing fre- 
quency. Postoperative cardiac dysfunction is the 
major cause of morbidity and mortality despite 
successful anatomic orrection and is more severe 
than after repair of acquired efects in adults with 
normoxic conditions. 1 Intraoperative management 
differs principally in that reversal of hypoxemia 
occurs with initiation of extracorporeal circulation 
and precedes the surgical ischemia used for opera- 
tive repair in children with cyanotic disease. 
The conventional method of starting CPB" in 
infants and children with hypoxemia is to raise 
oxygen tension (P02) to approximately 400 mm Hg 
by priming the extracorporeal circuit with hyperoxic 
fluid. We have speculated that this causes an "un- 
intended reoxygenation injury" that adds to subse- 
quent intraoperative stress when surgical ischemia is
needed to provide a bloodless field. 2 The role of 
reoxygenation injury as a contributory factor has yet 
to be established, despite experimental evidence 
that functional, biochemical, and structural alter- 
ations that follow reoxygenation are similar to 
changes that follow reperfusion after ischemia: 
these include stunned myocardium, 3' 4 lipid peroxi- 
dation, 5 enzyme release, 6 and necrosis. 7 Several 
clinical observations support his hypothesis nclud- 
ing (1) myocardial lipid peroxidation i preischemic 
right ventricular biopsy samples from children with 
cyanotic Conditions upported by CPB, 8 (2) reduced 
myocardial endogenous antioxidants incyanotic ver- 
sus normoxic patients, 9 (3) strong correlation be- 
tween Po 2 and endogenous antioxidant enzymes, a°
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(4) accentuated biochemical nd functional damage 
in cyanotic versus noncyanotic patients despite 
shorter ischemia nd comparable blood cardioplegia 
techniques, 11 and (5) reduced systolic function in 
patients with cyanotic disease supported by extra- 
corporeal membrane oxygenation because of respi- 
ratory failure, occasionally progressing to "cardiac 
stun" despite the absence of surgical ischemia, lz' ~3 
The normoxic immature myocardium has in- 
creased tolerance to ischemia because of adaptive 
mechanisms including increased glycolysis, 14 sub- 
strate level phosphorylation, 15 low 5'-nucleotidase 
levels, 16 and increased mitochondrial activity. 17 
These adaptations notwithstanding, cyanotic adult 
and immature hearts are less tolerant o intraoper- 
ative ischemia than normoxic hearts. 11' as, 19 Reac- 
tive oxygen intermediates are the common denom- 
inator that mediate reperfusion/reoxygenation 
injury, and superoxide anion (02-) may be a central 
effector in this damage, especially because reoxygen- 
ation is associated with a burst of superoxide anion 
(02-) 2o and CPB per se may generate reactive 
oxygen intermediates byaltering neutrophils, 2~com- 
plement, 22 and arachidonic acid metabolism. 23 Nor- 
mally; organs contain ubiquitous endogenous oxy- 
gen radical Scavengers (i.e., superoxide dismutase, 
catalase, reduced glutathione~ tocopherol, and vita- 
min C) that counteract the effects of toxic oxygen 
species (hydrogen peroxide, H202, and hydroxyl 
radical, OH.). Hyp0xia 5'24 and/or ischemia 25 de- 
plete tissue levels of these naturally occurring bar- 
riers to oxidant damage and increase vulnerability o 
reoxygenation i jury, especially because reoxygen- 
ation causes further eduction of antioxidants. 5 
Reoxygenation injury affects tissue other than the 
myocardiUm 26 and occurs without the confounding 
influence of CPB. For example, studies of lung 
reoxygenation show that pretreatment with oxygen 
radical scavengers 27 limits the pulmonary injury that 
follows reexpansion after chronic atelectasis. Addi- 
tionally, vascular endothelium is a well-recognized 
target after reintroduction of molecular oxygen, 
because reperfusion reduces coronary endothelial 
nitric oxide (.NO) production and subsequent endo- 
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thelial dependent relaxation and potentiates endo- 
thelial-derived contraction to favor coronary vaso- 
spasm. 2s A similar change may occur in the lung 27 so 
that the impaired capacity to produce endogenous 
• NO favors pulmonary vasoconstriction 29 and exog- 
enous • NO delivery may be required to reduce 
pulmonary vascular esistance. 3°
Reoxygenated human and bovine endothelial 
cells release superoxide anion (02-) and become 
potent generators of "OH, causing lipid peroxida- 
tion, protein sulfhydryl oxidation, and cross-linking, 
which leads to enzyme activation with ultimate 
extravasation of intravascular components, ignify- 
ing alteration of barrier function) 1Early endothe- 
lial cell membrane injury also promotes ubsequent 
neutrophil adherence and activation, leading to 
capillary plugging, reduced flow, and release of 
oxidants (i.e., 02-)  that may cause myocardial stun- 
ning, 32 with the global effect of causing the low 
output syndrome. 
Classically, reactive oxygen species mediate reper- 
fusion/reoxygenation injury via the Haber-Weiss 
(Fenton) pathway. An alternative xplanation was 
proposed recently by Beckman and associates 33
whereby superoxide anion (02-) and .NO react to 
form a cytotoxic 02 species. Recent studies show 
that reoxygenation of cyanotic infantile hearts sup- 
ported by CPB is associated with a burst of .NO that 
correlates with oxidant damage and myocardial dys- 
function, which could be limited by either adding 
• NO synthase inhibitors or antioxidants o the prim- 
ing solution of the CPB circuit. 2 .NO also mediates 
release of iron from ferritin, heme, and nonheme 
proteins, 34 and iron content rises eightfold to nine- 
fold after reoxygenation 35 to become available to 
react with hydrogen peroxide. Thus -NO may par- 
ticipate in the Haber-Weiss reaction, but by mech- 
anisms not appreciated previously, inasmuch as the 
role of "NO in the reperfusion/reoxygenation pro-
cess is emerging as ongoing research uncovers new 
actions of this substance. Deferoxamine is an iron 
chelator that limits reperfusion-related damage, 36 
but its precise mechanism of action in inhibiting 
metal-mediated oxidant injury is only now beginning 
to be revealed. 
The possibility exists, therefore, that there is a 
• NO paradox, like the 0 2 and calcium paradox, 37 
whereby a substance responsible for modulating 
normal physiologic functions (i.e., mediating vaso- 
dilation and reducing white blood cell margination 
and migration through the vessel wall and platelet 
adhesiveness, and so on) may become deleterious 
when produced in high concentrations on reoxygen- 
ation. The confusion over how the same substance 
can be both salutary and detrimental is resolved by 
recognizing that it may have different actions during 
and after reoxygenation. A similar apparent dichot- 
omy occurs with calcium, which accentuates reper- 
fusion injury immediately after restoring coronary 
blood flow after ischemia, yet is needed in normal or 
increased concentrations to modulate cardiac con- 
tractile capacity when CPB is discontinued. 
This manuscript introduces a series of studies of 
reoxygenation i jury in the immature cyanotic myo- 
cardium that (1) show that damage is, in part, 
iatrogenic and can be modified by altering the 
management of CPB, (2) explore the mechanisms of
reoxygenation injury, (3) define markers of damage, 
and (4) test various treatment protocols directed at 
its avoidance. Extrapolation of experimental find- 
ings to clinical events requires areasonable perspec- 
tive of the limitations of laboratory methods. 
Experimental models 
In vitro models of hypoxia/reoxygenation c firm 
the occurrence of O2-mediated damage, 5'24 but such 
models (1) preclude the evaluation of noncardiac 
effects of interventions (i.e., on pancreas and lung), 
(2) exclude neuroendocrine influences, (3) are ap- 
plicable only in studies of transplantation or circu- 
latory arrest because they are devoid of noncoronary 
collateral flow that washes out any cardioplegic 
solution used to limit surgical ischemic damage, (4) 
produce results that vary, depending on the perfu- 
sion medium, 38 and (5) may inadvertently combine 
hypoxia and ischemia, inasmuch as coronary blood 
flow is fixed and coronary perfusion pressure falls 
during hypoxic vasodilation. 39 A similar hypoxic/ 
ischemic insult may occur in the acute in vivo 
ventilator hypoxia model, because reduced inspired 
oxygen produces asphyxia, which may be associated 
with acidosis and hemodynamic deterioration, which 
does not occur in patients with chronic compensated 
cyanosis. 4° The in vivo model does, however, retain 
neuroendocrine influences, a physiologic perfusate 
(blood), and noncoronary collateral flow and per- 
mits determination of noncardiac effects of various 
interventions, thereby allowing extrapolation of ex- 
perimental results to the clinical setting. 
An in vivo model of hypoxia and reoxygenation 
with the use of CPB will be introduced in some 
studies to overcome the shortcomings of hemody- 
namic deterioration with ventilator hypoxia, but no 
short-term model allows development of the adap- 
1166 Buckberg 
The Journal of Thoracic and 
Cardiovascular Surgery 
October 1995 
1,6 ' 
1,2 " 
SWI 
(g x rn/kg) 
0.8" 
0.4 
. . .~  
°," 
°~°  
o' 
K °" 
Control 
X "}'  eo, 
0.0  i i 
0 5 10 15 20 25 
LAP (mmHg) 
Fig. 1. Cardiac functional reserve capacity evaluated by 
testing myocardial performance by volume infusion in 
nonhypoxemic ( ontrol) piglets and after 2 hours of 
hypoxia followed by reoxygenation (Re02) during CPB. 
SWI, Stroke work index; LAP, left atrial pressure. 
tive metabolic mechanisms to chronic hypoxemia 
that occur in patients with cyanotic onditions who 
undergo cardiac correction. Despite this, studies of 
chronically cyanotic neonatal lambs is and adult 
dogs 19 confirm the decreased ischemic tolerance of 
the cyanotic heart that characterizes acute hypoxia 
studies, and this decreased ischemic tolerance has 
been confirmed clinically. 1~ Unfortunately, few 
studies of chronic hypoxia have been reported 
because of high perioperative mortality and con- 
sequent expenditure of personnel and monetary 
cost for chronic care. Furthermore, chronically 
cyanotic hearts develop cardiac hypertrophy, 
which may confound results, 19 and, more impor- 
tant, they are always subjected to reoxygenation 
before testing of various cardioprotective strate- 
gies, so that the role of reoxygenation per se 
remains unexplored. 
Reserve capacity and subsequent stress 
Several methods to evaluate functional and bio- 
chemical effects of hypoxia and reoxygenation are 
available for study, and it seemed appropriate to 
place these into clinical perspective to emphasize 
the importance of evaluating reserve capacity in 
interpreting the effects of various interventions. The 
two measurements of myocardial reserve capacity 
made routinely in experimental studies and in clin- 
ical practice are the vasodilator and myocardial 
functional reserve capacity to provide insight into 
the capacity of the heart to either augment or 
maintain flow or function as demands for coronary 
blood flow or cardiac work increase. A third mea- 
surement, the antioxidant reserve capacity, is less 
well recognized, but has analogous implications 
because vulnerability to oxidant damage increases as 
endogenous tores of naturally occurring antioxi- 
dant defenses become depleted. 
Coronary vasodilator reserve capacity. We did 
not test coronary vasodilator eserve capacity in 
these studies, but mention it because this is a 
relevant and familiar experimental nd clinical mea- 
surement that evaluates both the resting and poten- 
tial response to stress. Patients with coronary dis- 
ease expend vasodilator reserve capacity to maintain 
flow beyond stenosis under resting conditions and 
ischemia develops when flow cannot be augmented 
further when the patients are stressed by treadmill 
testing. 
Myocardial functional reserve capacity. Cardiac 
contractile functional reserve capacity is evaluated 
clinically by assessment of response to volume infu- 
sion, whereby fiber stretch (preload) lengthens and 
cardiac output and blood pressure rise during trans- 
fusion per Starling's law of the heart (Fig. 1). 
Physiologists question this method of functional 
assessment because of the dependency of loading 
conditions and heart rate. 41 The availability of so- 
phisticated methods (i.e., conductance catheters, 
ultrasonic rystals, gated imaging methods) allows 
an instantaneous assessment of contractility in the 
laboratory setting through calculation of end-sys- 
tolic elastance or preload recruitable stroke work, or 
both. 42 These methods also have limitations 43 and 
are unavailable in routine clinical practice where the 
only evidence of depression is the need for a higher 
filling pressure (i.e., greater than 15 mm Hg left 
atrial pressure, greater than 10 mm Hg right atrial 
pressure) to achieve a normal cardiac index. This 
usual clinical endpoint of a "normal cardiac index" 
is at the bottom of the Starling curve (Fig. 1) and 
myocardial functional reserve capacity is tested 
rarely beyond this point. Conversely, functional re- 
serve capacity is tested routinely in experimental 
studies by varying preload by inferior vena caval 
occlusion or transfusion to supernormal cardiac 
indices; the inability to recruit increased contractile 
force is reported as the degree of functional depres- 
sion. This functional impairment may not be appar- 
ent readily from the bedside, aside from increased 
filling pressures, o that there is a natural tendency 
The Journal of Thoracic and 
Cardiovascular Surgery 
Volume 110, Number 4, Part 2 
Buckberg i 1 6 7 
to ascribe experimentally demonstrated functional 
depression to the artificiality of a laboratory setting 
(where function is actually tested) and to reject its 
occurrence clinically (where it is not tested) other 
than to increase volume loading to determine 
whether cardiac index reaches "normal evels." En- 
croachment on clinical functional reserve capacity 
becomes obvious when hearts with negligible r e- 
serve capacity undergo further contractile impair- 
ment when cardioprotective strategies are imper- 
fect. Under these conditions, the requirement for 
inotropic drugs become routine, and mechanical 
circulatory support is sometimes needed (intraaortic 
balloon or left- or right-sided ventricular assist 
devices). Conversely, a similar intraoperative insult 
is tolerated well by hearts with normal reserve 
capacity and impairment becomes evident only by a 
mild to moderate increased filling pressure to 
achieve anormal cardiac index or by minimum need 
for temporary inotropic support. 
Antioxidant reserve capacity. A third measure- 
ment of functional reserve capacity is the antioxi- 
dant reserve capacity. This is assessed in vitro by 
incubating cardiac muscle in varying concentrations 
of a standard oxidant and evaluating the extent of 
cardiac lipid peroxidation by malondialdehyde elab- 
oration (Fig. 2). The dose response is remarkably 
similar to the  effects of volume loading during 
inscription of Starling function curves hown in Fig. 
1 and there is close linkage between antioxidant 
depletion, oxidant damage, and cardiac dysfunction. 
The biochemical consequence of antioxidant de- 
pletion is more malondialdehyde g neration after 
exposure to a standard oxidant stimulus; the func- 
tional consequence is myocardial stunning charac- 
terized by lower stroke index at similar left atrial 
pressures) The clinical counterpart to this in vitro 
determination is increased vulnerability of previ- 
ously ischemic or hypoxic tissue to damage after 
application of similar surgical stress (i.e., a fixed 
duration of aortic clamping). Normal hearts with 
abundant antioxidant reserve capacity develop 
only minor functional impairment after a standard 
ischemic hallenge, whereas hearts with limited anti- 
oxidant reserve capacity exhibit more marked con- 
tractile depression. These observations explain also 
why pretreatment with antioxidants increases iseh- 
emic tolerance. 44 
Markers of oxidant damage 
The most commonly measured and widely used 
markers of oxidant injury are conjugated ienes and 
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Fig. 2. Antioxidant reserve capacity evaluated before hy- 
poxemia nd after 2 hours of hypoxemia nd reoxygen- 
ation (Re02) during CBP. 
malondialdehyde. Tissue is not usually available to 
test oxidative reserve capacity but elution of conju- 
gated dienes or thiobarbituric acid-related sub- 
stances to detect malondiaidehyde is generally re- 
garded as quantifying lipid peroxidation; these may 
also indicate a more generalized tissue insult be- 
cause they reflect also oxidant damage to carbohy- 
drates, proteins, amino acids, and deoxyribonucleic 
acid rather than lipids alone, as well as products 
generated uring the acid heating stage of the teSt. 45 
More recent data suggest that oxidant stress causes 
also a loss of protein sulfhydryls and rise in protein 
carbonyl derivatives, and specific methods are be- 
coming available for analysis of uric acid, 46 ascor- 
47 bate-dehydroscorbate, and reduced/oxygenized to- 
cophero147 to provide insight into the precise type of 
antioxidant that is depleted, as well as the target Site 
on membrane or cytosol where oxidant damage 
occurs. These more precise markers of oxidant 
stress notwithstanding, measurements of tissue and 
transmyocardial conjugated ienes and tissue anti- 
oxidant reserve capacity remain useful tools to (1) 
detect the occurrence of oxidant damage and (2) 
determine the status of endogenous antioxidant 
defense capacity. There is an inverse relationship 
between antioxidant reserve capacity and conju- 
gated diene elaboration. As oxidant damage in- 
creases, endogenous antioxidant reserve capacity 
becomes depleted (Fig. 2). 
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Current studies 
Using the aforementioned markers of oxidant 
damage, antioxidant reserve capacity, and functional 
reserve capacity, we will report a series of studies (1) 
providing evidence of reoxygenatio n injury with 
Verifilator hypoxia and reoxygenation by either the 
ventilator or CPB; we will introduce also a new 
model of hypoxia and reoxygenation during CPB 
that avoids the hemodynamic deterioration ttiat 
characterizes ventilator hypoxia, (2) comparing sim- 
ilar intervals of hypoxia/reoxygenation with isch- 
emia/reperfusion and showing hypoxia/reoxygen- 
ation is more deleterious, (3) examining the roles of 
the iron-related and L-arginine-nitric oxide path- 
ways in reoxygenati0n damage, (4) describing in vivo 
and in vitro studies of the antioxidants N-(2-mer- 
captopropionyl)-glycine, catalase, and coenzyme 
Q10 and deferoxamine showing how and why adding 
them to the prime of the extracorporeal circuit 
limits damage, (5) demonstrating that reoxygenation 
injury interferes with the cardioprote~tive effects of 
blood cardioplegia and that this is reversed by 
antioxidants, (6) assessing the role qf amino acid 
supplementation in the extracorporeal circuit prim- 
ing solution, (7) determining the effects of lowering 
Po 2 at the initiation of CPB and demonstrating that 
abrupt versus gradual reoxygenation is ineffective 
without other treatment protocols, (8) introducing 
the concept of controlled cardiac reoxygenation 
whereby reoxygenation is delayed until the blood 
cardioplegic solution is delivered, (9) defining the 
role of individual components of the blood car- 
dioplegic solution in limiting .NO-mediated cardiac 
damage, and (10) questioning the need to ever use 
hyperoxic management in cyanotic infants and sug- 
gesting that a~oidance of hyperoxia ig analogous to 
restricting inspired oxygen fraction in newborn in- 
fants to avoid retrolental fibroplasia. 
I anticipate that this series of studies will lead to 
the conclusion that reoxygenation i jury is a real 
source of postoperative cardiac dysfunction that can 
be modified and possibly ameliorated by a change in 
intraoperative management during initiation of CPB 
in children with cyanotic diseas6. It is hoped that the 
studies will provide a basis for developing strategies 
that increase the safety of extracorporeal circulation 
in infants with cyanotic disease and serve as a 
stimulus to subsequent s hdies of how modification 
of reoxygenation damage may lead to improved 
results during surgical repair of congenital defects 
causing cyanosis. 
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